163 results on '"Brawley O"'
Search Results
2. Cancer-related Disparities: Weathering the Perfect Storm Through Comprehensive Cancer Control Approaches
3. CE3 COMPARATIVE EFFECTIVENESS OF SYSTEMATIC THERAPIES FOR METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER: A PARAMETRIC SURVIVAL NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
4. PDG59 IS CURRENT TRIAL DATA SHARING STATUS CONDUCIVE FOR EVIDENCE GENERATION FOR PERSONALIZED MEDICINE: A FAILED ATTEMPT TO CONDUCT AN INDIVIDUAL PATIENT TRIAL DATA NETWORK META-ANALYSIS
5. Need for global action for cancer control
6. Alcohol: Science, policy and public health
7. Colorectal Cancer Control: Providing Adequate Care to Those Who Need It
8. Need for global action for cancer control
9. Prostate Cancer Screening: Biases and the Need for Consensus
10. Accelerating progress on non-communicable diseases
11. Trends in Prostate Cancer in the United States
12. Epilogue
13. Sixty Years of CA: A Cancer Journal for Clinicians
14. Effect of inflammation on prostate cancer incidence and dutasteride efficacy in the Reduction by Dutasteride of Cancer Events (REDUCE) study.
15. Introducing the 2010 American Cancer Society Prostate Cancer Screening Guideline
16. Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening
17. The Globalization of Tobacco Use: 21 Challenges For The 21st Century
18. From the Editors
19. Reviewer Acknowledgment 2009
20. 7006 Effect of baseline characteristics on prostate cancer rates and risk reduction in the Reduction by Dutasteride of prostate Cancer Events REDUCE) trial
21. The utility of PSA for detection of prostate cancer in men treated with dutasteride: Results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) study
22. Prostate Cancer Screening; Is This a Teachable Moment?
23. Taking Action to Ease Suffering: Advancing Cancer Pain Control as a Health Care Priority
24. Screening for Prostate Cancer
25. Prostate Cancer: Current Evidence Weighs Against Population Screening
26. Worldwide comparison of prostate needle biopsy quality in the reduction by dutasteride of prostate cancer events (REDUCE) study: Improvement with investigator training
27. Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening
28. Evaluation of treatment patterns and disparities in commercially insured patients newly-diagnosed with breast cancer
29. Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues
30. From the Outgoing and Incoming Editors-in-Chief
31. From the Editors
32. Differences in treatment in stage III breast cancer in African American women
33. Racial differences in treatment for breast cancer among black and white women in Atlanta
34. 727Baseline characteristics of patients in the reduce chemoprevention study
35. Some Perspective on Black-White Cancer Statistics
36. Disaggregating the Effects of Race and Poverty on Breast Cancer Outcomes
37. Geographic Variation in Breast Cancer Mortality for White and Black Women: 1986-1995
38. Potential Agents for Prostate Cancer Chemoprevention
39. Race and Outcomes: Is This the End of the Beginning for Minority Health Research?
40. National cancer clinical trials: Children have equal access; adolescents do not
41. Representation of African-Americans, Hispanics, and Whites in National Cancer Institute Cancer Treatment Trials
42. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.
43. After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.
44. A Randomized Pilot Study of Alternating or Simultaneous Zidovudine and Didanosine Therapy in Patients with Symptomatic Human Immunodeficiency Virus Infection
45. Assuring Access to State-of-the-Art Care for U.S. Minority Populations: the First 2 Years of the Minority-Based Community Clinical Oncology Program
46. A Pilot Study of Sequential Therapy with Zidovudine plus Acyclovir, Dideoxyinosine, and Dideoxycytidine in Patients with Severe Human Immunodeficiency Virus Infection
47. Re: Chemoprevention Studies in the Community Clinical Oncology Program
48. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups.
49. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.
50. Prostate cancer incidence and mortality rates among white and black men.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.